Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Genomic CDKN2A/2B deletions in adult Ph + ALL are adverse despite allogeneic stem cell transplantation

Blood (2018) 131 (13): 1464–1475.

https://doi.org/10.1182/blood-2017-07-796862

Published: 2018

Includes: Supplemental data

Journal Articles

Mutational hierarchies in myelodysplastic syndromes dynamically adapt and evolve upon therapy response and failure

Blood (2016) 128 (9): 1246–1259.

https://doi.org/10.1182/blood-2015-11-679167

Published: 2016

Includes: Supplemental data

Journal Articles

Application of a Short Tandem Repeat Based PCR Assay for Chronological Monitoring of Myelodysplastic Syndrome (MDS) Patients with Deletion of Chromosome 5q Following Lenalidomide Treatment

Blood (2015) 126 (23): 2891.

https://doi.org/10.1182/blood.V126.23.2891.2891

Published: 2015

Journal Articles

Clinical Impact of TP53 Mutations in Patients with MDS and Isolated Deletion 5(q) Treated with Lenalidomid: Results from the German Prospective Le-Mon-5 Trial

Blood (2014) 124 (21): 1920.

https://doi.org/10.1182/blood.V124.21.1920.1920

Published: 2014

Journal Articles

Development of a DNA-Based Targeted Assay Suitable for Accurate Quantification of Chromosomal Deletions in Myelodysplastic Syndromes with Deletion (5q) and Other Clonal Diseases

Johann-Christoph Jann, Daniel Nowak, Florian Nolte, Stephanie Fey, Verena Nowak, Julia Obländer, Jovita Pressler, Alice Fabarius, PhD, Claudia Haferlach, MD, Hind Medyouf, PhD, Wolf-Karsten Hofmann, Maximilian Mossner

Blood (2014) 124 (21): 1925.

https://doi.org/10.1182/blood.V124.21.1925.1925

Published: 2014

Journal Articles

Quantitative Analysis of Patient-Specific Lesions in Primary and Xenografted Myelodysplastic Syndromes Reveals Complex Hierarchies and Subclonal Diversity That Evolve during Disease Progression

Blood (2014) 124 (21): 4604.

https://doi.org/10.1182/blood.V124.21.4604.4604

Published: 2014

Journal Articles

Next Generation RNA Sequencing of Acute Promyelocytic Leukemia (APL) Identifies Novel Long Non Coding RNAs Including New Variants of MIR181A1HG That Are Differentially Expressed during Myeloid Differentiation

Frederic Lammer, Marion Klaumuenzer, PhD, Maximilian Mossner, Johann Christoph Jann, Anna Hecht, MD, Verena Nowak, Stephanie Fey, Julia Oblaender, Jovita Pressler, Eva Lengfelder, MD, Wolf-Karsten Hofmann, MD PhD, Daniel Nowak, MD

Blood (2014) 124 (21): 1031.

https://doi.org/10.1182/blood.V124.21.1031.1031

Published: 2014

Journal Articles

Gene Expression of the Erythroid Regulator Erythroferrone (ERFE) is Highly Deregulated in CD71+ Erythroprogenitor Cells of Patients with Myelodysplastic Syndromes and Demonstrates Prognostic Relevance

Maximilian Mossner, Alexandra Stöhr, Florian Nolte, Johann-Christoph Jann, Stephanie Fey, Verena Nowak, Julia Obländer, Jovita Pressler, Claudia D Baldus, Torsten J Schulze, MD, Martin Neumann, MD, Wolf-Karsten Hofmann, Daniel Nowak

Blood (2014) 124 (21): 4620.

https://doi.org/10.1182/blood.V124.21.4620.4620

Published: 2014

Journal Articles

The Fas Ligand Inhibitor APG101 in Transfusion Dependent Patients with Low Risk MDS: Interim Results from a Phase I Study

Evi launiger-Lörsch, Thomas Luft, Stephanie Fey, Julia Obländer, Susanne Brendel, Jovita Pressler, Johann-Christoph Jann, Claudia Kunz, Anthony D. Ho, Harald Fricke, Maximilian Mossner, Georgia Metzgeroth, Daniel Nowak, Wolf-Karsten Hofmann, Florian Nolte

Blood (2014) 124 (21): 4669.

https://doi.org/10.1182/blood.V124.21.4669.4669

Published: 2014

Journal Articles

Array-Based Integrative Analysis Of Epigenomic and Transcriptomic Alterations In CD71+ Bone Marrow Erythroprogenitor Cells From Patients With Myelodysplastic Syndromes

Maximilian Mossner, Axel Wilbertz, Stephanie Fey, Julia Obländer, Verena Nowak, Jovita Vogler, Florian Nolte, MD, Ralf Bieber, Wolf-Karsten Hofmann, MD, Mark Reinwald, MD, Daniel Nowak, MD

Blood (2013) 122 (21): 1561.

https://doi.org/10.1182/blood.V122.21.1561.1561

Published: 2013

Journal Articles

The New CD95 Ligand Inhibitor APG101 Leads To Decreased Apoptosis and Improved Erythroid Differentiation In Primary CD34+ Cells From Patients With Low Risk Myelodysplastic Syndrome (MDS)

Florian Nolte, MD, Claudia Kunz, Stephanie Fey, Julia Obländer, Susanne Brendel, Marion Klaumünzer, Maximilian Mossner, Johann-Christoph Jann, Stefanie Uhlig, Daniel Nowak, MD, Harald Fricke, MD, Wolf-Karsten Hofmann, MD

Blood (2013) 122 (21): 1562.

https://doi.org/10.1182/blood.V122.21.1562.1562

Published: 2013

Journal Articles

TP53 Mutations Detected By Next-Generation Deep-Sequencing In Patients With Myelodysplastic Syndrome and Isolated Deletion (5q): Results From a German Multicenter Trial

Blood (2013) 122 (21): 2759.

https://doi.org/10.1182/blood.V122.21.2759.2759

Published: 2013

Journal Articles

MDS-Derived Stromal Cells Exhibit Altered Gene Expression and Support The Engraftment Of lin - CD34 + CD38 - Disease-Initiating Stem Cells In a Xenograft Model Of Lower Risk MDS

Blood (2013) 122 (21): 100.

https://doi.org/10.1182/blood.V122.21.100.100

Published: 2013

Journal Articles

In Adult Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia, The Negative Prognostic Impact Of IKZF1, CDKN2A/B and PAX5 Deletions Is Not Abrogated By Allogeneic Stem Cell Transplantation In First Complete Remission

Heike Pfeifer, MD, Katharina Raum, Sandra Markovic, Stephanie Fey, Julia Obländer, Verena Nowak, Wunderle Lydia, MD, Fabian Lang, MD, Dieter Hoelzer, MD, Wolf-Karsten Hofmann, MD, Nicola Goekbuget, MD, Oliver G. Ottmann, MD, Daniel Nowak, MD

Blood (2013) 122 (21): 231.

https://doi.org/10.1182/blood.V122.21.231.231

Published: 2013

Journal Articles

Next Generation Sequencing-Based Molecular Dissection Of Lineage-Specific Mutational Hierarchies In Oligoclonal Primary and Xenografted Myelodysplasia

Johann-Christoph Jann, Daniel Nowak, MD, Florian Nolte, MD, Claudia Haferlach, MD, Marita Staller, Verena Nowak, Bettina Zens, Katja Müdder, Corinna Klein, Julia Obländer, Stephanie Fey, Jovita Vogler, Alice Fabarius, PhD, Alexander Kohlmann, PhD, Wolf-Karsten Hofmann, MD, Andreas Trumpp, PhD, Hind Medyouf, PhD, Maximilian Mossner

Blood (2013) 122 (21): 519.

https://doi.org/10.1182/blood.V122.21.519.519

Published: 2013

Journal Articles

Genome Wide DNA Methylation Analysis Identifies a Characteristic Methylation Profile for Patients with Acute Promyelocytic Leukemia and FLT3-Internal Tandem Duplication

Mark Reinwald, MD, Anjulie Haag, Eva Lengfelder, MD, Maximilian Mossner, Benjamin Hanfstein, MD, Verena Nowak, Marion Klaumuenzer, Florian Nolte, MD, Julia Oblaender, Stephanie Fey, Thomas Büchner, MD, Karsten Spiekermann, MD, Wolf-Karsten Hofmann, Daniel Nowak, MD

Blood (2012) 120 (21): 3521.

https://doi.org/10.1182/blood.V120.21.3521.3521

Published: 2012

Journal Articles

Significant Engraftment of Immature Hematopoietic Cells From Patients with Low Risk Myelodysplastic Syndromes (MDS) in Immunodeficient Mice

Hind Medyouf, PhD, Florian Nolte, MD, Maximilian Mossner, Verena Nowak, Bettina Zens, Katja Müdder, Julia Obländer, Stephanie Fey, Marion Klaumuenzer, Alice Fabarius, PhD, Eva Riedl, MD, Alexander Marx, MD, Henning Roehl, MD, Nadine Mueller, MD, Georgia Metzgeroth, MD, Gero Huetter, MD, Wolf-Karsten Hofmann, Andreas Trumpp, PhD, Daniel Nowak, MD

Blood (2012) 120 (21): 1694.

https://doi.org/10.1182/blood.V120.21.1694.1694

Published: 2012

Journal Articles

Genome Wide DNA Methylation Analysis of Patients with Myelodysplastic Syndrome and Isolated Deletion (5q) Reveals Characteristic Methylation Profiles in Low and Intermediate-1 Risk Groups

Mark Reinwald, MD, Daniel Nowak, MD, Uwe Platzbecker, MD, Aristoteles Giagounidis, MD, Katharina S. Götze, Oliver G. Ottmann, MD, Detlef Haase, Katayoon Shirneshan, Richard F Schlenk, MD, Anne Letsch, MD, Michael Lübbert, MD, Arnold Ganser, Verena Nowak, Stephanie Fey, Julia Obländer, Maximilian Mossner, Ulrich Germing, Wolf-Karsten Hofmann, MD, Florian Nolte, MD

Blood (2012) 120 (21): 3801.

https://doi.org/10.1182/blood.V120.21.3801.3801

Published: 2012

NARROW

Genomic CDKN2A/2B deletions in adult Ph + ALL are adverse despite allogeneic stem cell transplantation

Mutational hierarchies in myelodysplastic syndromes dynamically adapt and evolve upon therapy response and failure

Application of a Short Tandem Repeat Based PCR Assay for Chronological Monitoring of Myelodysplastic Syndrome (MDS) Patients with Deletion of Chromosome 5q Following Lenalidomide Treatment

Clinical Impact of TP53 Mutations in Patients with MDS and Isolated Deletion 5(q) Treated with Lenalidomid: Results from the German Prospective Le-Mon-5 Trial

Development of a DNA-Based Targeted Assay Suitable for Accurate Quantification of Chromosomal Deletions in Myelodysplastic Syndromes with Deletion (5q) and Other Clonal Diseases

Quantitative Analysis of Patient-Specific Lesions in Primary and Xenografted Myelodysplastic Syndromes Reveals Complex Hierarchies and Subclonal Diversity That Evolve during Disease Progression

Next Generation RNA Sequencing of Acute Promyelocytic Leukemia (APL) Identifies Novel Long Non Coding RNAs Including New Variants of MIR181A1HG That Are Differentially Expressed during Myeloid Differentiation

Gene Expression of the Erythroid Regulator Erythroferrone (ERFE) is Highly Deregulated in CD71+ Erythroprogenitor Cells of Patients with Myelodysplastic Syndromes and Demonstrates Prognostic Relevance

The Fas Ligand Inhibitor APG101 in Transfusion Dependent Patients with Low Risk MDS: Interim Results from a Phase I Study

Array-Based Integrative Analysis Of Epigenomic and Transcriptomic Alterations In CD71+ Bone Marrow Erythroprogenitor Cells From Patients With Myelodysplastic Syndromes

The New CD95 Ligand Inhibitor APG101 Leads To Decreased Apoptosis and Improved Erythroid Differentiation In Primary CD34+ Cells From Patients With Low Risk Myelodysplastic Syndrome (MDS)

TP53 Mutations Detected By Next-Generation Deep-Sequencing In Patients With Myelodysplastic Syndrome and Isolated Deletion (5q): Results From a German Multicenter Trial

MDS-Derived Stromal Cells Exhibit Altered Gene Expression and Support The Engraftment Of lin - CD34 + CD38 - Disease-Initiating Stem Cells In a Xenograft Model Of Lower Risk MDS

In Adult Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia, The Negative Prognostic Impact Of IKZF1, CDKN2A/B and PAX5 Deletions Is Not Abrogated By Allogeneic Stem Cell Transplantation In First Complete Remission

Next Generation Sequencing-Based Molecular Dissection Of Lineage-Specific Mutational Hierarchies In Oligoclonal Primary and Xenografted Myelodysplasia

Genome Wide DNA Methylation Analysis Identifies a Characteristic Methylation Profile for Patients with Acute Promyelocytic Leukemia and FLT3-Internal Tandem Duplication

Significant Engraftment of Immature Hematopoietic Cells From Patients with Low Risk Myelodysplastic Syndromes (MDS) in Immunodeficient Mice

Genome Wide DNA Methylation Analysis of Patients with Myelodysplastic Syndrome and Isolated Deletion (5q) Reveals Characteristic Methylation Profiles in Low and Intermediate-1 Risk Groups

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only